Form 4: Accelerate Diagnostics CFO David Patience Reports Stock Transactions
SEC Form 4 Filing
David Patience, CFO of Accelerate Diagnostics, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On April 9, 2024, David Patience, the CFO of Accelerate Diagnostics, had 37,468 restricted stock units (RSUs) vest.
- Each RSU represents the right to receive one share of Accelerate Diagnostics common stock.
- Patience sold 13,296 shares at $0.87 per share to cover tax withholding obligations related to the vesting of the RSUs.
- Following these transactions, Patience directly owns 50,419 shares of common stock and indirectly owns 760 shares through a spouse's IRA.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions by a company insider. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates activity related to equity compensation.
Stakeholder Impact
- The sale of shares by the CFO could have a minor, temporary impact on the stock price.
Key Dates
| Date | Description |
|---|---|
| March 5, 2024 | Reporting person was granted 37,468 restricted stock units |
| April 9, 2024 | Restricted stock units vested and shares were sold to cover tax obligations |
| April 10, 2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.